Thank you very much for this info. Whatever else others might incorrectly believe, it's hard to doubt that Eno knew and discussed options with Dugar in 2017. Secret deals are one thing; but publicly getting BioAmber's assets for $4.3M is quite another ... unless they knew each other.
Also ... once we learned that governments were involved with promoting forward-looking technologies, we had very good reasons for hanging on to our shares. More so, since we learned of some cigar-room discussions already in 2018.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.